Fasting hyperglycaemia following trans-catheter arterial chemoembolization for hepatocellular carcinoma in cirrhosis

Italian Journal of Gastroenterology and Hepatology

Volumn 29, Issue 5, 1997, Pages 427-433

  Farinati, F ^a,b,c   Rinaldi, M ^a,b,c   Del Prato, S ^a,b,c   Lana, S ^a,b,c   De Maria, N ^a,b,c   Paleari, D ^a,b,c   Marafm, C ^a,b,c   Naccarato, R ^a,b,c  

^a Department of Gastroenterology ^*  (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

^c UNIVERSITY HOSPITAL OF PADOVA   (Italy)

Author keywords

Chemoembolization; Chemotherapy; Cirrhosis; Diabetes; HCC; Liver tumours references

Indexed keywords

ALANINE AMINOTRANSFERASE; AMYLASE; C PEPTIDE; CORTICOTROPIN; GELFOAM; GLUCOSE; GROWTH HORMONE; HYDROCORTISONE; INSULIN; PANCREAS HORMONE; THYROID HORMONE; THYROTROPIN;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; AMYLASE BLOOD LEVEL; ARTICLE; ARTIFICIAL EMBOLISM; BODY TEMPERATURE; CARBOHYDRATE METABOLISM; CONTROLLED STUDY; CORTICOTROPIN BLOOD LEVEL; DIABETIC COMA; DISEASE SEVERITY; FEMALE; FEVER; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; GROWTH HORMONE BLOOD LEVEL; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPERGLYCEMIA; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FUNCTION; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PROGNOSIS; THYROTROPIN BLOOD LEVEL;

ADULT; AGED; AGED, 80 AND OVER; C-PEPTIDE; CARCINOMA, HEPATOCELLULAR; CHEMOEMBOLIZATION, THERAPEUTIC; FASTING; FEMALE; HORMONES; HUMANS; HYPERGLYCEMIA; INSULIN; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; MIDDLE AGED;

EID: 0031415818     PISSN: 11258055     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Petrides AS, Vogt C, Schulze-Berge D, Matthews D, Strohmeyer G. Pathogenesis of glucose intolerance and diabetes mellitus in cirrhosis. Hepatology 1994;19:616-27.
2. Muller MJ, Pirlich M, Balks HJ, Seiberg O. Glucose intolerance in liver cirrhosis: role of hepatic and non-hepatic influences. Eur J Clin Chem Biochem 1994;32:749-59.
3. Allison MED, Wreghitt T, Palmer CR, Alexander GJM. Evidence for a link between hepatitis C virus infection and diabetes mellitus in cirrhotic population. J Hepatol 1994;21:1135-9.
4. Kruszynska VT, Home PD, Mclntyre N. Relationship between insulin insensitivity, insulin secretion and glucose tolerance in cirrhosis. Hepatology 1991;14:103-11.
5. Leatherdale BA, Chase RA, Rogers J, Albert! KGMM, Davies P, Record CO. Forearm glucose uptake in cirrhosis and its relationship to glucose tolerance. Clin Sei 1980;59:191-8.
6. Merli M, Eriksson LS, Hagenfeldt L, Wahren J. Splanchnic and leg exchange of free fatty acids in patients with liver cirrhosis. J Hepatol 1986;3:348-55.
7. Seiberg O, Burchert W, Hoff J v.d., Mayer GJ, Hundeshagen H, Radoch E, et al. Insulin resistance in liver cirrhosis. Positron emission tomography scan analysis of skeletal muscle glucose metabolism. J Clin Invest 1993;91:1897-902.
8. Kruszynska YT, Meyer-Alber A, Darakshan F, Home PD, Mclntyre N. Metabolic handling of orally administered glucose in cirrhosis. J Clin Invest 1993;91:1057-66.
9. Pugh RNH, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transsection of the oesophagus for bleeding oesophageal varices, Br J Surg 1973;60:646-9.
10. Okuda K, Ohtsuki T, Obata H, Tomimatsu M, Okazaki N, Hasegavva H, et al. Natural history of HCC and prognosis in relation to treatment. Study of 850 patients. Cancer 1985;56:918-28.
11. Khan KNA, Nakata K, Shima M, Kusumoto Y, Ishii N, Koji T, et al. Pancreatic tissue damage by transcatheter arterial embolization forhepatoma. Dig Dis Sei 1993;38:65-70.
12. Gelding SV, Alberti KG, Johnston DG. The liver and the endocrine system. In: Millward-Sadler GH, Wright R, Arthur MJP, editors. Liver and biliary disease. London: WB Saunders, 1992:174-93.
13. Lindholm J. Steroid-binding proteins and the liver. In: Langer M, Chiandussi M, Chopra IJ, Martini L, editors. The endocrines and the liver. London: Academic Press, 1982:93-100.
14. Rizza RA, Mandarino LJ, Gerich JE. Effects of growth hormone on insulin action in man. Mechanism of insulin resistance, impaired suppression of glucose production and impaired stimulation of glucose utilisation. Diabetes 1982;31:663-9.
15. Langer M, Masala A, Rassu S. Growth hormone secretion in chronic liver disease. In: Langer M, Chiandussi L, Chopra IJ, Martini L, editors. The endocrines and the liver. London: Academic Press, 1982:278-87.
16. Kruszynska YT, Home PD, Hanning I, Alberti KGMM. Basal and 24-hr C-peptide and insulin secretion rate in normal man. Diabetologia 1987;30:16-21.
17. Andus T, Bauer J, Gerok W. Effects of cytokines on the liver. Hepatology 1991; 13:364-7.
18. Oellerich M, Räude E, Burdelski M, Schulz M, Schmidt FW, Ringe B, et al. Monoethylglycinexylidide formation kinetics: a novel approach to assessment of liver function. J Clin Chem Clin Biochem 1987;25:845-53.
19. Taourel P, Dauzat M, Lafortune M, Pradel J, Rossi M, Bruel JM. Hemodynamic changes after transcatheter arterial emboliza-tion of hepatocellular carcinomas. Radiology 1994;191:189-92.
20. Baba H, Zhang X-J, Kunkel K, Wolfe R. Effect of hepatectomy on glucose metabolism in the dog. Metabolism 1994;43:670-6.
21. Bianchi G, Marchesini G, Zoli M, Bugianesi E, Fabbri A, Pisi E. Prognostic significance of diabetes in patients with cirrhosis. Hepatology 1994;20:119-25.